Get all your news in one place.
100's of premium titles.
One app.
Start reading
Tribune News Service
Tribune News Service
Business
Mike Freeman

Biotech buyout: San Diego's Turning Point Therapeutics sells to Bristol Myers Squibb for $4.1 billion

Bristol Myers Squibb has inked a deal to buy San Diego's Turning Point Therapeutics for $4.1 billion in cash, strengthening the pharmaceutical giant's presence in precision cancer treatments.

Shareholders of Turning Point, which went public three years ago at $18 per share, will get $76 per share under terms of the transaction.

While that's a hefty gain from the IPO, it's still well below Turning Point's peak share price of $135.90 in February 2021.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.